Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Long-term Outcomes in Patients Recovering From Hepatitis B Liver Failure

Studies long-term outcomes and risk factors in adults recovered from hepatitis B liver failure.

Plain-language title generated from the registry record
Registry title: Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure

Key facts

Where
Guangzhou, ChinaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Source: NCT04310787, who can take part

Where in China

  • Third Affiliated Hospital of Sun Yat-sen UniversityGuangzhou, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Third Affiliated Hospital, Sun Yat-Sen University
Trial code
NCT04310787
Record updated
29 November 2024
Original description
This study is to investigate the long-term outcomes and prognostic risk factors in patients recovered from hepatitis B virus related acute on-chronic liver failure.Read full original descriptionShow less

The Investigation on Long-term Outcomes and Prognostic Factors of Patients With Hepatitis B Related Acute-on-chronic Liver Failure

This study is to investigate the long-term outcomes and prognostic risk factors in patients recovered from hepatitis B virus related acute on-chronic liver failure.

Inclusion: Age from 18 to 65 years old; The diagnosis consistent with hepatitis b associated chronic acute liver failure;; After hospitalization, the survival time > 90 days;; The inpatient clinical data are complete.

Exclusion: Human immunodeficiency virus infection or congenital immune deficiency diseases; Liver cancer and other tumors, autoimmune liver disease, genetic and metabolic liver disease, or other serious diseases that significantly affect patient survival; Other conditions that the researchers judged not appropriate for inclusion.

ClinicalTrials.gov NCT04310787